Citations

Mayo Clinic

Showing 10 of 108522 citations.

Preoperative endoscopic ultrasound-guided fine needle aspiration does not impair survival of patients with resected pancreatic cancer
Ngamruengphong, Saowanee , Swanson, Kristi M. , Shah, Nilay D. , Wallace, Michael B. , Wallace, Michael B

Gut | January 10, 2015 | Volume: 64 | Issue: 7 | Pages: 1105-1110

10.1136/gutjnl-2014-307475 | PMID 25575893 Get It

Objective Endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) allows preoperative tissue confirmation of malignancy, but fear of tumour cell dissemination along the needle track has limited its use. We hypothesised that if tumour cell dissemination occurs with EUS-FNA, survival after complete resection would be impaired. We aimed to evaluate the association of preoperative EUS-FNA with long-term outcomes of patients with resected pancreatic cancer. Design Using the linked Surveillance, Epidemiology, and End Results (SEER)–Medicare data, we identified patients with locoregional pancreatic cancer who underwent curative intent surgery from 1998 to 2009. The patients who received EUS-FNA within the peridiagnostic period were included in the EUS-FNA group. Patients who did not receive EUS evaluation or who underwent EUS without FNA were included in the non-EUS-FNA group. Overall survival and pancreatic cancer-specific survival were compared after controlling for relevant covariates. Results A total of 2034 patients with pancreatic cancer were included (90% pancreatic adenocarcinoma). Of these, 498 (24%) patients were in EUS-FNA group. Patients with multiple comorbidities and more recent diagnosis were more likely to receive EUS-FNA. In multivariate analysis, after controlling for age, race, gender, tumour histology, tumour stage, tumour grade, tumour location, SEER site, year of diagnosis, undergoing percutaneous aspiration/biopsy, Charlson Comorbidity Index, radiation and chemotherapy, EUS-FNA was marginally associated with improved overall survival (HR 0.84, 95% CI 0.72 to 0.99), but did not affect cancer-specific survival (HR 0.87, 95% CI 0.74 to 1.03). Conclusions Preoperative EUS-FNA was not associated with increased risk of mortality. These data suggest that EUS-FNA can be safely performed for the work-up of suspicious pancreatic lesions.
Disseminated adenovirus disease in heart transplant recipient presenting with conjunctivitis
Bruminhent, Jackrapong , Athas, Deena M., Hess, Bryan , Flomenberg, Phyllis , Bruminhent, Jackrapong

Transplant Infectious Disease | January 9, 2015 | Volume: 17 | Issue: 1 | Pages: 125-128

10.1111/tid.12342 | PMID 25571908 Get It

AbstractWe report a 65‐year‐old heart transplant recipient who presented with conjunctivitis, likely acquired from a family member who worked at a daycare center during an outbreak of conjunctivitis. He developed a severe adenoviral pneumonitis, which was successfully treated with intravenous cidofovir combined with a reduction of immunosuppression.
Technical Modifications in the Repair of Acute Ischemic Posterior Ventricular Septal Defect Without Ventriculotomy
Murashita, Takashi , Greason, Kevin L. , Suri, Rakesh M. , Joyce, David L. , Stulak, John M., Schaff, Hartzell V. , Schaff, Hartzell

Journal of Cardiac Surgery | January 9, 2015 | Volume: 30 | Issue: 3 | Pages: 233-237

10.1111/jocs.12498 | PMID 25571774 Get It

PVAAS: identify variants associated with aberrant splicing from RNA-seq
Wang, Liguo , Nie, Jinfu, Kocher, Jean‐Pierre , Nie, Jinfu J, Wang, Liguo

Bioinformatics | January 9, 2015 | Volume: 31 | Issue: 10 | Pages: 1668-1670

10.1093/bioinformatics/btv001 | PMID 25573917 Get It

Abstract Motivation: RNA-seq has been widely used to study the transcriptome. Comparing to microarray, sequencing-based RNA-seq is able to identify splicing variants and single nucleotide variants in one experiment simultaneously. This provides unique opportunity to detect variants that associated with aberrant splicing. Despite the popularity of RNA-seq, no bioinformatics tool has been developed to leverage this advantage to identify variants associated with aberrant splicing. Results: We have developed PVAAS, a tool to identify single nucleotide variants that associated with aberrant alternative splicing from RNA-seq data. PVAAS works in three steps: (i) identify aberrant splicings; (ii) use user-provided variants or perform variant calling; (iii) assess the significance of association between variants and aberrant splicing events. Availability and implementation: PVAAS is written in Python and C. Source code and a comprehensive user’s manual are freely available at: http://pvaas.sourceforge.net/. Contact: wang.liguo@mayo.edu or kocher.jeanpierre@mayo.edu Supplementary information: Supplementary data are available at Bioinformatics online.
Anticoagulation during pregnancy in women with prosthetic valves: evidence, guidelines and unanswered questions
Nishimura, Rick A., Warnes, Carole A.

Heart | January 9, 2015 | Volume: 101 | Issue: 6 | Pages: 430-435

10.1136/heartjnl-2014-306500 | PMID 25573983 Get It

The management of women with mechanical heart valves during pregnancy remains difficult and controversial. There is no ideal anticoagulation regimen for this unique population, as there are inherent risks and benefits of each approach for both mother and fetus. There has been limited data available to guide the clinician in the optimal treatment strategy for an individual patient. The AHA/ACC Guidelines for the Management of Patients with Valvular Heart Disease created class recommendations for this population based upon current evidence, which is summarized in this review.
Nanopore-Based Assay for Detection of Methylation in Double-Stranded DNA Fragments
Shim, Jiwook , Humphreys, Gwendolyn I., Nardulli, Ann M., Kosari, Farhad , Vasmatzis, George , Ahlquist, David A. , Myong, Sua , Kim, Young-Hoon , Taylor, William R. , Bashir, Rashid

ACS Nano | January 8, 2015 | Volume: 9 | Issue: 1 | Pages: 290-300

10.1021/nn5045596 | PMID 25569824 Get It

A Five-Year-Old Child with a Subcutaneous Forehead Nodule
Westblade, Lars F. , Fischer, Peter , Haghi, Nina, Schniederjan, Matthew , Pritt, Bobbi S. , Long, John G., Jerris, Robert C. , Garola, Robert E., Pritt, Bobbi S

Pediatric and Developmental Pathology | January 8, 2015 | Volume: 18 | Issue: 2 | Pages: 164-166

10.2350/14-08-1545-cr.1 | PMID 25569144 Get It

We describe a case of a 5-year-old girl with onchocerciasis. The patient was recently adopted from Ethiopia and presented with a firm, raised nodule on the midportion of the forehead. Initially, Langerhans cell histiocytosis with bone involvement was suspected; however, histopathologic analysis of the excised nodule revealed the presence of a young-adult, female Onchocerca volvulus worm. This case exemplifies the importance of recognizing the key morphologic characteristics of adult O. volvulus worms isolated from pediatric patients in nonendemic areas to ensure adroit clinical management.
Diastolic Function in Patients with Hypertrophic Cardiomyopathy: Evaluation Using the Phase-contrast MRI Measurement of Mitral Valve and Pulmonary Vein Flow Velocities
Lee, Sang-Chol, Oh, Jae K. , Kim, Eun Young , Choe, Yeon Hyeon , Kim, Sung Mok , Lee, Sang-Chol, Chang, Sung‐A

Journal of the Korean Society of Magnetic Resonance in Medicine | January 8, 2015 | Volume: 18 | Issue: 4 | Pages: 314

10.13104/jksmrm.2014.18.4.314 Get It

Use of Flattening Filter Free Photon Beams for Off-axis Targets in Conformal Arc Stereotactic Body Radiation Therapy
Serago, Christopher F., Hintenlang, Kathleen, Vallow, Laura A., Peterson, Jennifer , Hintenlang, David E., Buskirk, Steven J., Smith, Ashley A. , Kim, Siyong , Ko, Stephen J. , Heckman, Michael G.

Progress in Medical Physics | January 8, 2015 | Volume: 25 | Issue: 4 | Pages: 288

10.14316/pmp.2014.25.4.288 Get It

Stratification of hepatocellular carcinoma risk in primary biliary cirrhosis: a multicentre international study
Lammers, Willem J. , Buuren, Henk R. van , Parés, Albert , Floreani, Annarosa , Janssen, Harry L.A. , Invernizzi, Pietro , Battezzati, Pier Maria , Ponsioen, Cyriel Y. , Poupon, Raoul , Mayo, Marlyn J. , Burroughs, Andrew K. , Nevens, Frederik , Lleò, Ana , Caballería, Llorenç , Lindor, Keith D. , Hirschfield, Gideon M. , Bruns, Tony , Boonstra, Kirsten , Trivedi, Palak Jitendrakumar , Corpechot, Christophe , Mason, Andrew L. , Kowdley, Kris V. , Hansen, Bettina E. , Bruns, Tony , Invernizzi, Pietro , Hirschfield, Gideon M

Gut | January 8, 2015 | Volume: 65 | Issue: 2 | Pages: 321-329

10.1136/gutjnl-2014-308351 | PMID 25567117 Get It

Objective Hepatocellular carcinoma (HCC) is an infrequent yet critical event in primary biliary cirrhosis (PBC); however, predictive tools remain ill-defined. Our objective was to identify candidate risk factors for HCC development in patients with PBC. Design Risk factor analysis was performed in over 15 centres from North America and Europe spanning >40 years observation period using Cox proportional hazards assumptions, logistic regression, and Kaplan-Meier estimates. Results Of 4565 patients with PBC 123 developed HCC, yielding an incidence rate (IR) of 3.4 cases/1000 patient-years. HCC was significantly more common in men (p<0.0001), and on univariate analysis factors at PBC diagnosis associated with future HCC development were male sex (unadjusted HR 2.91, p<0.0001), elevated serum aspartate transaminase (HR 1.24, p<0.0001), advanced disease (HR 2.72, p=0.022), thrombocytopenia (HR 1.65, p<0.0001), and hepatic decompensation (HR 9.89, p<0.0001). As such, non-treatment with ursodeoxycholic acid itself was not associated with cancer development; however, 12-month stratification by biochemical non-response (Paris-I criteria) associated significantly with future risk of HCC (HR 4.52, p<0.0001; IR 6.6 vs 1.4, p<0.0001). Non-response predicted future risk in patients with early stage disease (IR 4.7 vs 1.2, p=0.005), advanced disease (HR 2.79, p=0.02; IR 11.2 vs 4.4, p=0.033), and when restricting the analysis to only male patients (HR 4.44, p<0.001; IR 18.2 vs 5.4, p<0.001). On multivariable analysis biochemical non-response remained the most significant factor predictive of future HCC risk (adjusted HR 3.44, p<0.0001). Conclusions This uniquely powered, internationally representative cohort robustly demonstrates that 12-month biochemical non-response is associated with increased future risk of developing HCC in PBC. Such risk stratification is relevant to patient care and development of new therapies.